Professor, Radiology, Mayo Medical School
Radiology
Dr. Val J. Lowe, MD
|
|
Give Review
Val J. Lowe, MD practices Radiology. Lowe is a published doctor. He published 87 publications, including: 'Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.' Val J. Lowe accepts Medicare payments and is listed with Medicare.gov.
Publications
- Regional β-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia.
- Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study.
- Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
- Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
- Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
- Accelerated vs. unaccelerated serial MRI based TBM-SyN measurements for clinical trials in Alzheimer's disease.
- Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
- Microbleeds in Atypical Presentations of Alzheimer's Disease: A Comparison to Dementia of the Alzheimer's Type.
- Salvage lymph node dissection for prostate cancer nodal recurrence detected by 11C-choline positron emission tomography/computerized tomography.
- White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
- Perceived Misinterpretation Rates in Oncologic 18F-FDG PET/CT Studies: A Survey of Referring Physicians.
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.
- The evolution of primary progressive apraxia of speech.
- Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
- APOE ε4 influences β-amyloid deposition in primary progressive aphasia and speech apraxia.
- Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits.
- (18)F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
- Diabetes and Elevated Hemoglobin A1c Levels Are Associated with Brain Hypometabolism but Not Amyloid Accumulation.
- FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants.
- 18F-FDG PET Scanning in Pulmonary Amyloidosis.
- Multimodal Nanoprobes to target cerebrovascular amyloid in Alzheimer's disease brain.
- Progranulin-associated PiB-negative logopenic primary progressive aphasia.
- Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.
- Amyloid burden correlates with cognitive decline in Alzheimer's disease presenting with aphasia.
- The pimple sign of progressive supranuclear palsy syndrome.
- Orthotopic VX rabbit tongue cancer model with FDG-PET and histologic characterization.
- Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
- Selective Worsening of Brain Injury Biomarker Abnormalities in Cognitively Normal Elderly Persons With β-Amyloidosis.
- Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
- Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
- Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.
- Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.
- Rare Presentations of Primary Melanoma and Special Populations: A Systematic Review.
- Microbleeds in the logopenic variant of primary progressive aphasia.
- A hand-held beta imaging probe for FDG.
- Brain β-amyloid load approaches a plateau.
- Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: An MRI and FDG-PET study.
- The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
- The GGGGCC Repeat Expansion in C9ORF72 in a Case with Discordant Clinical and FDG-PET Findings: PET Trumps Syndrome.
- Effect of lifestyle activities on Alzheimer disease biomarkers and cognition.
- Operational Characteristics Of 11 C-Choline PET/CT For Prostate Cancer Patients With Biochemical Recurrence Following Initial Treatment.
- Oncologic 18F-FDG PET/CT: Referring Physicians' Point of View.
- Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.
- Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.
- Multimodality imaging characteristics of dementia with Lewy bodies.
- A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain.
- False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the se...
- Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies.
- The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma.
- Comparison of 18F-FDG and PiB PET in cognitive impairment.
- Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis.
- Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.
- Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis.
- The role of FDG-PET and staging laparoscopy in the management of patients with cancer of the esophagus or gastroesophageal junction.
- Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
- 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma.
- Using fluorodeoxythymidine to monitor anti-EGFR inhibitor therapy in squamous cell carcinoma xenografts.
- Plasma membrane phospholipid labeling to estimate tumor burden and kinetics.
- The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
- Recommendations on the use of 18F-FDG PET in oncology.
- Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
- Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
- The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
- In vivo quantitation of intratumoral radioisotope uptake using micro-single photon emission computed tomography/computed tomography.
- Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT.
- Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor.
- Normal uptake of F-18 FDG in the sublingual gland.
- Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.
- Lung cancer screening experience: a retrospective review of PET in 22 non-small cell lung carcinomas detected on screening chest CT in a high-risk population.
- Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
- Update in PET imaging of nonsmall cell lung cancer.
- Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses.
- 18F-FDG PET of patients with Hürthle cell carcinoma.
- Positron emission tomography for basal cell carcinoma of the head and neck.
- The utility of positron emission tomography in the evaluation of autoimmune hearing loss.
- Clinical 18F-FDG oncology patient preparation techniques.
- Positron emission tomography scanning in lung cancer.
- Cholangiocarcinoma metastatic to the neck: first report of a case.
- Assessment of Lymphoma Therapy Using (18)F-FDG PET.
- The usefulness of subtraction ictal SPECT coregistered to MRI in single- and dual-headed SPECT cameras in partial epilepsy.
- Esophageal cancer and head and neck cancer.
- Serial Evaluation of Increased Chest Wall F-18 Fluorodeoxyglucose (FDG) Uptake Following Radiation Therapy in Patients With Bronchogenic Carcinoma.
- Structural and functional imaging in parkinsonian syndromes.
- Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain.
- Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?
- FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer's Type.
Doctors Specialties
- Nuclear Medicine
- Radiology
Accepted Insurances
- Choice Plus POS II
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Commercial Insurance Company
- CoreSource
- GEHA
- Choice Care PPO
- Medica
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- Priority Health
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Education
-
Duke University Hospital -
McGill University Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1730166885 |
| Last Name Of The Provider | LOWE |
| First Name Of The Provider | VAL |
| View All |
Similar Doctors
|
|
Dr. Daryl C. Bergen, MD |
|
|
Dr. Thomas D. Atwell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy P. Maus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Welch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricio Fajnwaks, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jolanta M. Durski, MD |
|
|
Dr. Brian P. Mullan, MD |